Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang, Jianjun Yang, Ailin Luo, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen, Lonnie P. Wollmuth, Derek Bowie, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1469-1658
Open Access | Times Cited: 445
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
Biochemical Pharmacology (2020) Vol. 177, pp. 113935-113935
Open Access | Times Cited: 188
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 161
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
Wei Yao, Qianqian Cao, Shilin Luo, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 3, pp. 1618-1629
Open Access | Times Cited: 157
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Satoshi Deyama, Ronald S. Duman
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172837-172837
Open Access | Times Cited: 148
A historical review of antidepressant effects of ketamine and its enantiomers
Wei Yan, Lijia Chang, Kenji Hashimoto
Pharmacology Biochemistry and Behavior (2020) Vol. 190, pp. 172870-172870
Open Access | Times Cited: 140
The antidepressant actions of ketamine and its enantiomers
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108431-108431
Open Access | Times Cited: 72
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 54
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Brain region–specific action of ketamine as a rapid antidepressant
Min Chen, Shuangshuang Ma, Hanxiao Liu, et al.
Science (2024) Vol. 385, Iss. 6709
Closed Access | Times Cited: 20
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
Kai Zhang, Chun Yang, Lijia Chang, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 100
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 856-856
Open Access | Times Cited: 86
Ketamine for depression
Luke A. Jelen, James Stone
International Review of Psychiatry (2021) Vol. 33, Iss. 3, pp. 207-228
Closed Access | Times Cited: 70
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
Yating Wang, Xiaole Wang, Sitong Feng, et al.
Pharmacological Research (2021) Vol. 171, pp. 105761-105761
Closed Access | Times Cited: 56
Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
Vesna Lazarevic, Yunting Yang, Ivana Flais, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7425-7435
Open Access | Times Cited: 56
(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105635-105635
Open Access | Times Cited: 52
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41
Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine
Li Ma, Jiancheng Zhang, Yūkō Fujita, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Jenessa N. Johnston, Maximillian Greenwald, Ioline D. Henter, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 4, pp. 103518-103518
Open Access | Times Cited: 36
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Neuroinflammation through the vagus nerve-dependent gut–microbiota–brain axis in treatment-resistant depression
Kenji Hashimoto
Progress in brain research (2023), pp. 61-77
Closed Access | Times Cited: 31
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top